Literature DB >> 26840900

Correction: The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.

Young Eun Lee, Jaeyeol An, Kee-Hang Lee, Sung Su Kim, Hye Jin Song, Heejang Pyeon, Hyun Nam, Kyeongjin Kang, Kyeung Min Joo.   

Abstract

Entities:  

Year:  2016        PMID： 26840900      PMCID： PMC4740438          DOI： 10.1371/journal.pone.0148720

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The following information is missing from the Funding and Acknowledgments sections: This research was supported by a grant (NRF-2013R1A1A2058169) from the National Research Foundation.
  1 in total

1.  The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.

Authors:  Young Eun Lee; Jaeyeol An; Kee-Hang Lee; Sung Su Kim; Hye Jin Song; Heejang Pyeon; Hyun Nam; Kyeongjin Kang; Kyeung Min Joo
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240
  1 in total
  3 in total

Review 1.  Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Yunhua Zhu; Xin Qin; Min Zhang; Lihong Zhai; Yi Luo; Xiaoming He; Chun Mao; Wenbin Deng
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

2.  Effects of Long-Term In Vitro Expansion on Genetic Stability and Tumor Formation Capacity of Stem Cells.

Authors:  Hyun Nam; In-Hee Lee; Jason K Sa; Sung Soo Kim; Hee-Jang Pyeon; Kee Hang Lee; Kyunghoon Lee; Sun-Ho Lee; Kyeung Min Joo
Journal:  Stem Cell Rev Rep       Date:  2021-11-04       Impact factor: 5.739

Review 3.  An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase-Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

Authors:  Li Bo; Tan Guojun; Guo Li
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.